Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
410 | 3 | ONCOGENE//TRANSCRIPTION FACTOR//CELL BIOLOGY | 30938 |
3936 | 2 | PIM KINASE//TCTP//PIM 1 | 882 |
18760 | 1 | PIM KINASE//PIM 1//PIM 2 | 561 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PIM KINASE | authKW | 2445003 | 10% | 81% | 54 |
2 | PIM 1 | authKW | 1953088 | 12% | 51% | 68 |
3 | PIM 2 | authKW | 1294351 | 4% | 96% | 24 |
4 | PIM 3 | authKW | 1294351 | 4% | 96% | 24 |
5 | PIM 1 KINASE | authKW | 1186762 | 5% | 81% | 26 |
6 | PIM1 | authKW | 1119668 | 6% | 59% | 34 |
7 | PIM 1 KINASE INHIBITORS | authKW | 337071 | 1% | 100% | 6 |
8 | PIM KINASE INHIBITOR | authKW | 305858 | 1% | 78% | 7 |
9 | SGI 1776 | authKW | 305858 | 1% | 78% | 7 |
10 | CANC MICROENVIRONM PROGRAM | address | 252800 | 1% | 75% | 6 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 2249 | 34% | 0% | 189 |
2 | Chemistry, Medicinal | 1053 | 13% | 0% | 75 |
3 | Cell Biology | 1002 | 23% | 0% | 128 |
4 | Biochemistry & Molecular Biology | 588 | 29% | 0% | 165 |
5 | Hematology | 429 | 9% | 0% | 51 |
6 | Genetics & Heredity | 82 | 6% | 0% | 36 |
7 | Medicine, Research & Experimental | 81 | 6% | 0% | 32 |
8 | Chemistry, Organic | 79 | 7% | 0% | 39 |
9 | Biophysics | 38 | 4% | 0% | 23 |
10 | Immunology | 23 | 5% | 0% | 28 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC MICROENVIRONM PROGRAM | 252800 | 1% | 75% | 6 |
2 | PANCREAS HEPATOBILIARY | 112357 | 0% | 100% | 2 |
3 | THER EUT PROT DISCOVERY | 112357 | 0% | 100% | 2 |
4 | MOL BIOREGULAT | 81538 | 2% | 10% | 14 |
5 | CANC SHANGHAI CANC | 72226 | 1% | 43% | 3 |
6 | ABO AKAD UNIV | 67129 | 1% | 17% | 7 |
7 | EXPT THER EUT PROGRAMME | 65933 | 2% | 13% | 9 |
8 | AG HARTMANN | 56179 | 0% | 100% | 1 |
9 | AUTOIMMUNE TRANSPLANTAT INFLAMMATORY DIS AREA | 56179 | 0% | 100% | 1 |
10 | BUGNARD | 56179 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1552 | 5% | 0% | 27 |
2 | ONCOGENE | 1314 | 4% | 0% | 21 |
3 | ONCOGENE RESEARCH | 1273 | 0% | 1% | 2 |
4 | ONCOTARGET | 1090 | 3% | 0% | 18 |
5 | ACS MEDICINAL CHEMISTRY LETTERS | 941 | 1% | 0% | 5 |
6 | BLOOD | 750 | 4% | 0% | 22 |
7 | MOLECULAR CANCER RESEARCH | 706 | 1% | 0% | 5 |
8 | BLOOD CANCER JOURNAL | 663 | 0% | 1% | 2 |
9 | MOLECULAR CANCER THERAPEUTICS | 643 | 1% | 0% | 7 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 482 | 2% | 0% | 14 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIM KINASE | 2445003 | 10% | 81% | 54 | Search PIM+KINASE | Search PIM+KINASE |
2 | PIM 1 | 1953088 | 12% | 51% | 68 | Search PIM+1 | Search PIM+1 |
3 | PIM 2 | 1294351 | 4% | 96% | 24 | Search PIM+2 | Search PIM+2 |
4 | PIM 3 | 1294351 | 4% | 96% | 24 | Search PIM+3 | Search PIM+3 |
5 | PIM 1 KINASE | 1186762 | 5% | 81% | 26 | Search PIM+1+KINASE | Search PIM+1+KINASE |
6 | PIM1 | 1119668 | 6% | 59% | 34 | Search PIM1 | Search PIM1 |
7 | PIM 1 KINASE INHIBITORS | 337071 | 1% | 100% | 6 | Search PIM+1+KINASE+INHIBITORS | Search PIM+1+KINASE+INHIBITORS |
8 | PIM KINASE INHIBITOR | 305858 | 1% | 78% | 7 | Search PIM+KINASE+INHIBITOR | Search PIM+KINASE+INHIBITOR |
9 | SGI 1776 | 305858 | 1% | 78% | 7 | Search SGI+1776 | Search SGI+1776 |
10 | PIM KINASE INHIBITION | 234076 | 1% | 83% | 5 | Search PIM+KINASE+INHIBITION | Search PIM+KINASE+INHIBITION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 32183 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
2 | 38706 | UBAP2L//AMMONIA INDUCED APOPTOSIS//BAD APOPTOSIS PATHWAY |
3 | 36999 | VLIFE MDS//GROUP BASED QSAR//G QSAR |
4 | 17211 | CSK//CHK//CSK HOMOLOGOUS KINASE |
5 | 6535 | FLT3//FLT3 ITD//INTERNAL TANDEM DUPLICATION |
6 | 3595 | FRIEND VIRUS//JOURNAL OF VIROLOGY//PERSISTENT VIRAL DIS |
7 | 29481 | TPL2//TPL 2//MAP3K8 |
8 | 15105 | PROSTATE STEM CELLS//NKX31//YCR CANC UNIT |
9 | 35236 | MICRORNA 130B//MIR 130B//MIR 130A |
10 | 22102 | AEG 1//ASTROCYTE ELEVATED GENE 1//METADHERIN |